Cobalt whole blood concentrations in healthy adult male volunteers following two-weeks of ingesting a cobalt supplement

Food and Chemical Toxicology

Volumn 53, Issue , 2013, Pages 432-439

  Tvermoes, Brooke E ^a   Finley, Brent L ^a   Unice, Kenneth M ^b   Otani, Joanne M ^a   Paustenbach, Dennis J ^a   Galbraith, David A ^a  

^a CARDNO CHEMRISK   (United States)

^b ChemRisk LLC   (United States)

Author keywords

Absorption; Biokinetics; Biomonitoring; Cobalt; Dietary supplements; Whole blood

Indexed keywords

COBALT;

ARTICLE; BLOOD ANALYSIS; BLOOD LEVEL; BODY BURDEN; CONCENTRATION (PARAMETERS); DIET SUPPLEMENTATION; DIETARY INTAKE; ENERGY DRINK; HUMAN; HUMAN EXPERIMENT; MALE; NORMAL HUMAN; STEADY STATE; UNITED STATES;

EID: 84873571439     PISSN: 02786915     EISSN: 18736351     Source Type: Journal    
DOI: 10.1016/j.fct.2012.11.033     Document Type: Article

References (90)

1. American Conference of Industrial Hygienists (ACGIH), 2001. Cobalt, All Inorganic Forms, Except Cobalt Oxides: BEI. American Conference of Industrial Hygienists, Cincinnati, OH.
2. Alimonti A., Bocca B., Mannella E., Petrucci F., Zennaro F., Cotichini R., D'Ippolito C., Agresti A., Caimi S., Forte G. Assessment of reference values for selected elements in a healthy urban population. Ann. Ist. Super. Sanita 2005, 41:181-187.
3. Antoniou J., Zukor D.J., Mwale F., Minarik W., Petit A., Huk O.L. Metal ion levels in the blood of patients after hip resurfacing: a comparison between twenty-eight and thirty-six-millimeter-head metal-on-metal prostheses. J. Bone Joint Surg. Am. 2008, 90:142-148.
4. Agency for Toxic Substances and Disease Registry (ATSDR), 2004. Toxicological Profile for Cobalt. U.S. Department of Health and Human Services, Public Health Service, Agency for Toxic Substances and Disease Registry, Atlanta, GA.
5. Bailey R.L., Gahche J.J., Lentino C.V., Dwyer J.T., Engel J.S., Thomas P.R., Betz J.M., Sempos C.T., Picciano M.F. Dietary supplement use in the United States, 2003-2006. J. Nutr. 2011, 141:261-266.
6. Beck F.K., Rosenthal T.C. Prealbumin: a marker for nutritional evaluation. Am. Fam. Physician 2002, 65:1575-1578.
7. Berlin N.I. The distribution of cobalt in polycythemic rats. J. Biol. Chem. 1950, 187:41-45.
8. Bito R., Hino S., Baba A., Tanaka M., Watabe H., Kawabata H. Degradation of oxidative stress-induced denatured albumin in rat liver endothelial cells. Am. J. Physiol. Cell Physiol. 2005, 289:C531-C542.
9. Borderie D., Allanore Y., Meune C., Devaux J.Y., Ekindjian O.G., Kahan A. High ischemia-modified albumin concentration reflects oxidative stress but not myocardial involvement in systemic sclerosis. Clin. Chem. 2004, 50:2190-2193.
10. Bowie E.A., Hurley P.J. Cobalt chloride in the treatment of refractory anaemia in patients undergoing long-term haemodialysis. Aust. NZ J. Med. 1975, 5:306-314.
11. Briefel R.R., Johnson C.L. Secular trends in dietary intake in the United States. Annu. Rev. Nutr. 2004, 24:401-431.
12. Brodner W., Bitzan P., Meisinger V., Kaider A., Gottsauner-Wolf F., Kotz R. Serum cobalt levels after metal-on-metal total hip arthroplasty. J. Bone Joint Surg. Br. 2003, 85-A:2168-2173.
13. Centers for Disease Control and Prevention (CDC), 2011. Appendix C - Supplementary exposure limits. Retrieved on August 14, 2012, from: <>, NIOSH Guide to Chemical Hazards. National Institute for Occupational Safety and Health, Centers for Disease Control and Prevention, Atlanta, GA. http://www.cdc.gov/Niosh/npg/nengapdxc.html.
14. Christensen J.M., Poulsen O.M., Thomsen M. A short-term cross-over study on oral administration of soluble and insoluble cobalt compounds: sex differences in biological levels. Int. Arch. Occup. Environ. Health 1993, 65:233-240.
15. Curtis J.R., Goode G.C., Herrington J., Urdaneta L.E. Possible cobalt toxicity in maintenance hemodialysis patients after treatment with cobaltous chloride: a study of blood and tissue cobalt concentrations in normal subjects and patients with terminal renal failure. Clin. Nephrol. 1976, 5:61-65.
16. Daniel J., Ziaee H., Pradhan C., McMinn D.J. Six-year results of a prospective study of metal ion levels in young patients with metal-on-metal hip resurfacings. J. Bone Joint Surg. Br. 2009, 91:176-179.
17. Daniel J., Ziaee H., Pradhan C., McMinn D.J.W., Pynsent P.B. Renal clearance of cobalt in relation to the use of metal-on-metal bearings in hip arthroplasty. J. Bone Joint Surg. Am. 2010, 92:840-845.
18. Desert Rain Nutrition (DRN), 2012. Liquid Ionic Angstrom Cobalt. Retrieved on January 19, 2012, from: <>. Desert Rain Nutrition, Silt, CO. http://www.desertrainnutrition.com/index.php?main_page=product_info&cPath=1_8&products_id=192.
19. Duckham J.M., Lee H.A. The treatment of refractory anaemia of chronic renal failure with cobalt chloride. Q. J. Med. 1976, 45:277-294.
20. Edel J., Pozzi G., Sabbioni E., Pietra R., Devos S. Metabolic and toxicological studies on cobalt. Sci. Total Environ. 1994, 150:233-244.
21. European Food Safety Authority (EFSA) Scientific opinion on the use of cobalt compounds as additives in animal nutrition. EFSA J. 2009, 7:1-45.
22. Expert Group on Vitamins and Minerals (EGVM) Safe Upper Levels for Vitamins and Minerals 2003, Food Standards Agency, London.
23. Elinder C.-G., Friberg L. Cobalt. Handbook on the Toxicology of Metals 1986, 211-232. Elsevier, New York, NY, Sole distributors for the USA and Canada, Elsevier Science Pub. Co., Amsterdam; New York. second ed. L. Friberg, G. Nordberg, V.B. Vouk (Eds.).
24. Engh C.A., MacDonald S., Sritulanondha S., Thompson A., Naudie D., Engh C. Metal ion levels after metal-on-metal total hip arthroplasty: a randomized trial. Clin. Orthop. 2009, 467:101-111.
25. Provisional Peer Reviewed Toxicity Values for Cobalt (CASRN 7440-48-4) 2008, Environmental Protection Agency (EPA), Environmental Protection Agency (EPA), Cincinnati, OH.
26. Finley, B.L., Monnot, A.D., Paustenbach, D.J., Gaffney, S.H., 2012a. Derivation of a chronic oral reference dose for cobalt. Regul. Toxicol. Pharmacol. 64, 491-503.
27. Finley, B. L., A. D. Monnot, et al. (2012b). Dose-response relationships for blood cobalt concentrations and health effects: A review of the literature and application of a biokinetic model. J. Toxicol. Env. Heal B. http://dx.doi.org/10.1080/10937404.2012.744287.
28. Gardner F.H. The use of cobaltous chloride in the anemia associated with chronic renal disease. J. Lab. Clin. Med. 1953, 41:56-64.
29. Gross R.T., Kriss J.P., Spaet T.H. The hematopoietic and goitrogenic effects of cobaltous chloride in patients with sickle cell anemia. Pediatrics 1955, 15:284-290.
30. Harp M.J., Scoular F.I. Cobalt metabolism of young college women on self-selected diets. J. Nutr. 1952, 47:67-72.
31. Hoback J. State of the Supplements Industry 2010 2011, NewHope 360, Boulder, CO.
32. Cobalt in Hard Metals and Cobalt Sulfate, Gallium Arsenide, Indium Phosphide and Vanadium Pentoxide. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans 2006, vol. 86. International Agency for Research on Cancer (IARC), World Health Organization, Lyon, France.
33. Jaimet C.H., Thode H.G. Thyroid function studies on children receiving cobalt therapy. JAMA 1955, 158:1353-1355.
34. Jelkmann W., Lundby C. Blood doping and its detection. Blood 2011, 118:2395-2404.
35. Kriss J.P., Carnes W.H., Gross R.T. Hypothyroidism and thyroid hyperplasia in patients treated with cobalt. JAMA 1955, 157:117-121.
36. Lauwerys R., Lison D. Health risks associated with cobalt exposure - an overview. Sci. Total Environ. 1994, 150:1-6.
37. Leggett R.W. The biokinetics of inorganic cobalt in the human body. Sci. Total Environ. 2008, 389:259-269.
38. Letourneau E.G., Jack G.C., McCullough R.S., Hollins J.G. The metabolism of cobalt by the normal human male: whole body retention and radiation dosimetry. Health Phys. 1972, 22:451-459.
39. Licht A., Oliver M., Rachmilewitz E.A. Optic atrophy following treatment with cobalt chloride in a patient with pancytopenia and hypercellular marrow. Isr. J. Med. Sci. 1972, 8:61-66.
40. Lin, C.T.J., 2007. Section N. Prevalence of supplement use in the past 12 months, 2002 Health and Diet Survey: Topline Frequency Report (November 2007). Retrieved on October 11, 2012, from: <>. U.S. Food and Drug Administration, Silver Spring, MD. http://www.fda.gov/Food/ScienceResearch/ResearchAreas/ConsumerResearch/ucm202786.htm#sectn.
41. Lindquist G. Diet starts Monday: an analysis of current U.S. dietary supplement regulations through an international comparison. St. Louis Univ. J. Health Law Policy 2009, 3:123-152.
42. Lippi G., Franchini M., Guidi G.C. Blood doping by cobalt. Should we measure cobalt in athletes?. J. Occup. Med. Toxicol. 2006, 1:18.
43. MacDonald S.J., McCalden R.W., Chess D.G., Bourne R.B., Rorabeck C.H., Cleland D., Leung F. Metal-on-metal versus polyethylene in hip arthroplasty: a randomized clinical trial. Clin. Orthop. 2003, 282-296.
44. Manifold I., Platts M., Kennedy A. Cobalt cardiomyopathy in a patient on maintenance haemodialysis. Br. Med. J. 1978, 2:1609.
45. Marik P.E., Flemmer M. Do dietary supplements have beneficial health effects in industrialized nations: what is the evidence?. JPEN J. Parenter. Enteral. Nutr. 2012, 36:159-168.
46. Mother Earth Minerals Inc. (MEMI), 2011. Cobalt. Retrieved on January 5, 2011 from: <>. Mother Earth Minerals Inc., Ogden, UT. http://www.meminerals.com/catalog/ProductDetails.asp?ProductID=MINE4S00XEI8Co&DealerID=&Express=1.
47. Mineralife, 2012. Cobalt - Liquid Ionic Supplement. Retrieved on July 31, 2012, from: <>. Mineralife, Colorado Springs, CO. http://www.ionicliquidminerallife.com/ionic/Cobalt-Trace-Mineral--b-1029.asp.
48. Minoia C., Sabbioni E., Apostoli P., Pietra R., Pozzoli L., Gallorini M., Nicolaou G., Alessio L., Capodaglio E. Trace element reference values in tissues from inhabitants of the European community. I. A study of 46 elements in urine, blood and serum of Italian subjects. Sci. Total Environ. 1990, 95:89-105.
49. Morsy S.M., el-Assaly F.M. Body elimination rates of 134Cs, 60 Co and 203 Hg. Health Phys. 1970, 19:769-773.
50. Moshtaghie A.A., Badii A., Mohammadian T. The comparative study of binding characteristics of cobalt and iron to human serum transferrin. J. Res. Med. Sci. 2004, 9:250-254.
51. Neter J., Wasserman W., Kutner M.H. Chapter 15. Analysis of Factor Level Effects. Section 15.3 Tukey Method of Multiple Comparisons, Applied Linear Statistical Models: Regression, Analysis of Variance, and Experimental Designs 1990, Irwin, Homewood, IL, pp. 580-585. third ed.
52. National Institutes of Health (NIH), 1994. Dietary Supplement Health and Education Act of 1994. Dietary Supplement Health and Education Act of 1994. Public Law 103-417, 103RD Congress. Office of Dietary Supplements, National Institutes of Health, Bethesda, MD.
53. Background Information: Dietary Supplements 2011, National Institutes of Health (NIH), Office of Dietary Supplements, National Institutes of Health, Bethesda, MD.
54. Nutritional Outlook, 2011. How many dietary supplement GMP inspections has FDA performed so far? In Nutritional Outlook. Retrieved on July 31, 2012, from: <>. UBM Canon, Los Angeles, CA. http://www.nutritionaloutlook.com/print/7331.
55. Oettl K., Stauber R.E. Physiological and pathological changes in the redox state of human serum albumin critically influence its binding properties. Br. J. Pharmacol. 2007, 151:580-590.
56. Onkelinx C. Compartment analysis of cobalt (II) metabolism in rats of various ages. Toxicol. Appl. Pharmacol. 1976, 38:425-438.
57. Paley K.R., Sussman E.S. Absorption of radioactive cobaltous chloride in human subjects. Metabolism 1963, 12:975-982.
58. Pedigo N.G., George W.J., Anderson M.B. Effects of acute and chronic exposure to cobalt on male reproduction in mice. Reprod. Toxicol. 1988, 2:45-53.
59. Reuber S., Kreuzer M., Kirchgessner M. Interactions of cobalt and iron in absorption and retention. J. Trace Elem. Electrolytes Health Dis. 1994, 8:151-158.
60. Roche M., Layrisse M. Effect of cobalt on thyroidal uptake of I131. J. Clin. Endocrinol. Metab. 1956, 16:831-833.
61. Ryan G. FDA Supplement Guidance Likely to Remain Onerous, Attys Say. June 21, 2012 2012, Law360, New York.
62. Saxena S., Shukla D., Khan Y.A., Singh M., Bansal A., Sairam M., Jain S.K. Hypoxia preconditioning by cobalt chloride enhances endurance performance and protects skeletal muscles from exercise-induced oxidative damage in rats. Acta Physiol. 2010, 200:249-263.
63. Schirrmacher U.O. Case of cobalt poisoning. Br. Med. J. 1967, 1:544-545.
64. Schleisner P. Cobalt in anaemia. Acta Med. Scand. 1956, 154:177-185.
65. Schroeder H.A., Nason A.P., Tipton I.H. Essential trace metals in man: cobalt. J. Chronic Dis. 1967, 20:869-890.
66. Shrivastava K., Bansal A., Singh B., Sairam M., Ilavazhagan G. Sub-chronic oral toxicity study in Sprague-Dawley rats with hypoxia mimetic cobalt chloride towards the development of promising neutraceutical for oxygen deprivation. Exp. Toxicol. Pathol. 2010, 62:489-496.
67. Simonsen L.O., Brown A.M., Harbak H., Kristensen B.I., Bennekou P. Cobalt uptake and binding in human red blood cells. Blood Cells Mol. Dis. 2011, 46:266-276.
68. Simonsen L.O., Harbak H., Bennekou P. Passive transport pathways for Ca(2+) and Co(2+) in human red blood cells. (57)Co(2+) as a tracer for Ca(2+) influx. Blood Cells Mol. Dis. 2011, 47:214-225.
69. Simonsen L.O., Harbak H., Bennekou P. Cobalt metabolism and toxicology - a brief update. Sci. Total Environ. 2012, 432C:210-215.
70. Smith T., Thompson B.D., Barnaby C.F. Measurements of 60Co organ burdens in rats and their use in calculations of equilibrium dose-rates to various organs of man. Health Phys. 1971, 20:195-204.
71. Smith T., Edmonds C.J., Barnaby C.F. Absorption and retention of cobalt in man by whole-body counting. Health Phys. 1972, 22:359-367.
72. Sorbie J., Olatunbosun D., Corbett W.E., Valberg L.S. Cobalt excretion test for the assessment of body iron stores. Can. Med. Assoc. J. 1971, 104:777-782.
73. Taylor A., Marks V. Cobalt: a review. J. Hum. Nutr. 1978, 32:165-177.
74. Taylor, A., Marks, V., Shabaan, A.A., Mahmood, H.A., Duckham, J.M., Lee, H.A., 1977. Cobalt-induced lipaemia and erythropoiesis, Clinical Chemistry and Chemical Toxicology of Metals: Proceedings of the First International Symposium, pp. 105-108.
75. Thomas R.G., Furchner J.E., London J.E., Drake G.A., Wilson J.S., Richmond C.R. Comparative metabolism of radionuclides in mammals - X. Retention of tracer-level cobalt in the mouse, rat, monkey and dog. Health Phys. 1976, 31:323-333.
76. Tipton I.H., Cook M.J. Trace elements in human tissue. II. Adult subjects from the United States. Health Phys. 1963, 9:103-145.
77. U.S. Department of Human and Health Services (DHHS), 2003. Dietary Supplement Labels: An Assessment. March 2003. OEI-01-01-00121. Office of Inspector General, U.S. Department of Health and Human Services, Washington, DC.
78. U.S. Department of Human and Health Services (DHHS), 2011. Draft Guidance for Industry: Dietary Supplements: New Dietary Ingredient Notifications and Related Issues. July 2011. Office of Inspector General, U.S. Department of Health and Human Services, Washington, DC.
79. U.S. Food and Drug Administration (FDA), 2012a. What is a " new dietary ingredient" in a dietary supplement?, Dietary Supplements - Q&A. Retrieved on October 11, 2012, at: <>. U.S. Food and Drug Administration, Silver Spring, MD. http://www.fda.gov/Food/DietarySupplements/ConsumerInformation/ucm191930.htm#new_ds.
80. U.S. Food and Drug Administration (FDA), 2012b. Vitamin B12. Retrieved on December 11, 2012, at: <>. U.S. Food and Drug Administration, Silver Spring, MD. http://www.fda.gov/Food/GuidanceComplianceRegulatoryInformation/GuidanceDocuments/FoodLabelingNutrition/FoodLabelingGuide/ucm064928.htm.
81. U.S. Government Accountability Office (GAO), 2009. Dietary Supplements: FDA Should Take Further Actions to Improve Oversight and Consumer Understanding. Report to Congressional Requesters. January 2009. GAO-09-250. U.S. Govt. Accountability Office, Washington, D.C.
82. Unice K., Monnot A., Gaffney S.H., Tvermoes B., Thuett K., Paustenbach D., Finley B. Inorganic cobalt supplementation: prediction of cobalt levels in whole blood and urine using a biokinetic model. Food Chem. Toxicol. 2012, 50:2456-2461.
83. Valberg L.S., Ludwig J., Olatunbosun D. Alteration in cobalt absorption in patients with disorders of iron metabolism. Gastroenterology 1969, 56:241-251.
84. Vendittoli P.A., Mottard S., Roy A.G., Dupont C., Lavigne M. Chromium and cobalt ion release following the Durom high carbon content, forged metal-on-metal surface replacement of the hip. J. Bone Joint Surg. Br. 2007, 89:441-448.
85. Walter L.R., Marel E., Harbury R., Wearne J. Distribution of chromium and cobalt ions in various blood fractions after resurfacing hip arthroplasty. J. Arthroplasty 2008, 23:814-821.
86. Cobalt and Inorganic Cobalt Compounds. Concise International Chemical Assessment Document: 69 2006, World Health Organization (WHO), World Health Organization, Geneva.
87. Wolf J., Levy I.J. Treatment of sickle cell anemia with cobalt chloride. Arch. Intern. Med. 1954, 93:387-396.
88. Wright J.V. Bio-identical steroid hormone replacement: selected observations from 23 years of clinical and laboratory practice. Ann. NY Acad. Sci. 2005, 1057:506-524.
89. Yamagata N., Murata S., Torii T. The cobalt content of human body. J. Radiat. Res. (Tokyo) 1962, 3:4-8.
90. Zipfizz Corp, 2011. Energy Shot. Retrieved on October 11, 2012, from: <>. Zipfizz Corp, Mill Creek, WA. http://www.zipfizz.com/es2.html.